Guo HX - Search Results

1

Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.

Zhang Q, Yuan XF, Lu Y, Li ZZ, Bao SQ, Zhang XL, Yang YY, Fan DM, Zhang YZ, Wu CX, Guo HX, Zhang YJ, Ye Z, Xiong DS. Zhang Q, et al. Among authors: guo hx. Int J Cancer. 2017 Oct 1;141(7):1445-1457. doi: 10.1002/ijc.30846. Epub 2017 Jul 7. Int J Cancer. 2017. PMID: 28643325

2

[Cloning and expression of the extracellular domain of 4-1BBL].

Jiang WG, Xiong DS, Shao XF, Wang JH, Xu YF, Liu F, Guo HX, Zhu ZP, Yang CZ. Jiang WG, et al. Among authors: guo hx. Sheng Wu Gong Cheng Xue Bao. 2005 Sep;21(5):703-7. Sheng Wu Gong Cheng Xue Bao. 2005. PMID: 16285508 Chinese.

3

[The role of extracellular domain of human 4-1BBL in regulating activities of human peripheral blood lymphocytes in vitro].

Guo HX, Cheng X, Su Y, Fan DM, Shao XF, Xu YF, Yang CZ, Xiong DS. Guo HX, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 May;24(5):431-3. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008. PMID: 18466693 Chinese.

4

Extracellular domain of 4-1BBL enhanced the antitumoral efficacy of peripheral blood lymphocytes mediated by anti-CD3 x anti-Pgp bispecific diabody against human multidrug-resistant leukemia.

Guo H, Jiang W, Liu W, Gao Y, Yang M, Zhou Y, Wang J, Qi J, Cheng X, Zhu Z, Yang C, Xiong D. Guo H, et al. Cell Immunol. 2008 Feb;251(2):102-8. doi: 10.1016/j.cellimm.2008.04.006. Epub 2008 May 14. Cell Immunol. 2008. PMID: 18482719

5

[Study on the construction and expression of the human 4-1BBL extracellular domain/anti-CD20 Fab' fusion protein].

Jiang W, Xiong D, Liu F, Guo H, Su Y, Lü J, Yang C. Jiang W, et al. Sheng Wu Gong Cheng Xue Bao. 2008 Mar;24(3):376-80. Sheng Wu Gong Cheng Xue Bao. 2008. PMID: 18589811 Chinese.

6

Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodies.

Liu R, Jiang W, Yang M, Guo H, Zhang Y, Wang J, Zhu H, Shi R, Fan D, Yang C, Zhu Z, Xie Y, Xiong D. Liu R, et al. J Immunother. 2010 Jun;33(5):500-9. doi: 10.1097/CJI.0b013e3181d75c20. J Immunother. 2010. PMID: 20463597

7

Extracellular domain of human 4-1BBL enhanced the function of cytotoxic T-lymphocyte induced by dendritic cell.

Wu C, Guo H, Wang Y, Gao Y, Zhu Z, Du Z. Wu C, et al. Cell Immunol. 2011;271(1):118-23. doi: 10.1016/j.cellimm.2011.06.013. Epub 2011 Jun 23. Cell Immunol. 2011. PMID: 21745658

8

Astragaloside IV-enhanced anti-hepatocarcinoma immunity of dendritic cells.

Guo H, Zhao J, Wu C. Guo H, et al. Asian J Surg. 2022 May;45(5):1216-1218. doi: 10.1016/j.asjsur.2022.01.074. Epub 2022 Feb 28. Asian J Surg. 2022. PMID: 35241335 Free article. No abstract available.

9

An extracellular matrix-based signature associated with immune microenvironment predicts the prognosis of patients with hepatocellular carcinoma.

Zhang X, Jiang M, Zhang X, Zhang J, Guo H, Wu C. Zhang X, et al. Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101877. doi: 10.1016/j.clinre.2022.101877. Epub 2022 Mar 5. Clin Res Hepatol Gastroenterol. 2022. PMID: 35257959 Free article.

10

Efficacy and safety of camrelizumab combined with chemotherapy in the treatment of advanced biliary malignancy and associations between peripheral blood lymphocyte subsets and clinical outcomes.

Zhao J, Guo H, Wu C, Guo H. Zhao J, et al. Clin Transl Oncol. 2024 Sep 18. doi: 10.1007/s12094-024-03707-x. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39294513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters